We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Siemens Partners with Hamamatsu to Expand Into Digital Pathology in Americas and Europe

By LabMedica International staff writers
Posted on 09 Mar 2023

Today, digital pathology is at a tipping point, with the evolution from glass to digital already transforming standards of care. More...

This transformation is being driven by the technological combination of high-speed, high-resolution imaging; trusted medical data storage; fast, secure data transmission; and intuitive, inter-operable workflows with continual improvements in AI.

Siemens Healthineers (Erlangen, Germany) has entered into a multi-year distribution agreement with Hamamatsu (Shizuoka, Japan), under which Hamamatsu will provide NanoZoomer whole slide scanners to support Siemens’ expansion into digital pathology in the Americas and Europe.

Hamamatsu, a leading manufacturer of photonics devices, including whole slide scanners for digital pathology, has more than 60 years of experience in photonics engineering. The company has developed NanoZoomer scanners which are renowned for their image quality, reliability, and ease of use. Siemens has decades of experience in diagnostics, enterprise imaging, and healthcare IT. The partnership with Hamamatsu NanoZoomer whole slide scanners will help Siemens close the gap between radiology and pathology to achieve full potential of digital operations in patient care.

"This partnership between Hamamatsu and Siemens Healthineers will create tremendous value for laboratories and healthcare ecosystems," said, Fumio Iwase, Executive Officer, Division Director, Systems Division at Hamamatsu Photonics K.K., who believes that integrating complex hardware and software solutions into pathologists' workflow is critical to maximizing the potential of digital pathology in clinical environments. "Together, we will help laboratories across healthcare systems adopt digital pathology by seamlessly integrating pathologists' workflow with hardware to provide the utmost patient care."

"We now complement our portfolio for digital pathology with the products and expertise of Hamamatsu," added Christian Zapf, Head of Digital & Automation at Siemens Healthineers. "Together with our strong Syngo Carbon portfolio in enterprise imaging IT, we can now help our customers to comprehensively gain the benefits of a digital transformation in digital pathology."

Related Links:
Siemens Healthineers 
Hamamatsu 


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sample Transportation System
Tempus1800 Necto
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Illustration of a cross-section of a blood vessel with red blood cells, white blood cells, and fragments of DNA (Photo Courtesy of UC San Diego/Adobe Firefly)

Microbial DNA Signature in Blood Plasma Differentiates Two Liver Cancer Types

Determining whether a cancerous tumor originated in a given location or spread from another organ is critical for guiding diagnosis and treatment decisions. When the primary tumor site cannot be identified,... Read more

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.